Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Verbeelen

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Experimental Nephrology|January 11, 2001
Angiotensin II administration causes enhanced expression of glomerulosclerosis-related markers and decreased renal antioxidant enzyme activities in ratsD De Craemer, E Lobe, M Pauwels, et al.
Nephron|January 1, 1997
Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidneyC Van den Branden, R Verelst, J Vamecq, et al.
Acta Clinica Belgica|January 1, 1975
Parathyroid function and urinary cyclic 3'5' adenosine monophosphateN de Nutte, M Debacker, D Verbeelen, et al.
European Urology|January 1, 1978
Chemical analysis of renal stones from 377 Belgian patients by using qualitative or quantitative methodsM Fuss, J Simon, D Verbeelen, et al.
Nephron|January 1, 1997
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanololC Van den Branden, M Gabriels, J Vamecq, et al.
Journal of Clinical Pathology|March 1, 1982
Intracellular immunoglobulin distribution of bone marrow plasma cells as a diagnostic aid for primary amyloidosisC Thielemans, W Aelbrecht, D Verbeelen, et al.
Klinische Wochenschrift|July 1, 1980
Renal responsiveness to parathyroid hormone in a case of nonfamilial hypophosphatemic osteomalaciaM de Backer, N de Nutte, D Verbeelen, et al.
Acta Clinica Belgica|January 1, 1976
Urinary cyclic AMP during thyrocalcitonin treatment of patients with Paget's disease of boneR Six, D Verbeelen, N De Nutte, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Red blood cells indices and aluminium toxicity in haemodialysis patientsC Tielemans, L Kalima, F Collart, et al.
The American Journal of Medicine|September 18, 1989
Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiencyR L Lins, R Daelemans, M Dratwa, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Experimental Nephrology|January 11, 2001
Angiotensin II administration causes enhanced expression of glomerulosclerosis-related markers and decreased renal antioxidant enzyme activities in ratsD De Craemer, E Lobe, M Pauwels, et al.
Nephron|January 1, 1997
Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidneyC Van den Branden, R Verelst, J Vamecq, et al.
Acta Clinica Belgica|January 1, 1975
Parathyroid function and urinary cyclic 3'5' adenosine monophosphateN de Nutte, M Debacker, D Verbeelen, et al.
European Urology|January 1, 1978
Chemical analysis of renal stones from 377 Belgian patients by using qualitative or quantitative methodsM Fuss, J Simon, D Verbeelen, et al.
Nephron|January 1, 1997
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanololC Van den Branden, M Gabriels, J Vamecq, et al.
Journal of Clinical Pathology|March 1, 1982
Intracellular immunoglobulin distribution of bone marrow plasma cells as a diagnostic aid for primary amyloidosisC Thielemans, W Aelbrecht, D Verbeelen, et al.
Klinische Wochenschrift|July 1, 1980
Renal responsiveness to parathyroid hormone in a case of nonfamilial hypophosphatemic osteomalaciaM de Backer, N de Nutte, D Verbeelen, et al.
Acta Clinica Belgica|January 1, 1976
Urinary cyclic AMP during thyrocalcitonin treatment of patients with Paget's disease of boneR Six, D Verbeelen, N De Nutte, et al.
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress|January 1, 1985
Red blood cells indices and aluminium toxicity in haemodialysis patientsC Tielemans, L Kalima, F Collart, et al.
The American Journal of Medicine|September 18, 1989
Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiencyR L Lins, R Daelemans, M Dratwa, et al.
Pageof 8